PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma.

Yokoyama D, Hisamori S, Deguchi Y, Nishigori T, Okabe H, Kanaya S, Manaka D, Kadokawa Y, Hata H, Minamiguchi S, Tsunoda S, Obama K, Sakai Y
Sci Rep. 2021 Apr 27;11(1):9013. doi: 10.1038/s41598-021-88331-3. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.